Group items tagged

Apollo Hospitals has the best team of the surgical medical gastroenterologist in across India. We provide the best doctors, specialist consulting, treatment, Surgical Medical Gastroenterologist facilities.

Artemis Hospitals has a team of the best gastroenterologist in Gurgaon, Delhi for treatment of liver & digestive diseases which ensures high quality of care.

Dr Piyush Ranjan is a very famous Gastroenterologist. He is a well known and prestigious doctor specializes in the diagnosis and treatment of liver diseases.

In peptiko.gr, visitors and patients can find general information in Greek concerning a wide range of gastrointestinal symptoms; diseases; diagnostic tests (gastroscopy, colonoscopy, polypectomy) and their relative preparations; diets; and prevention methods for diseases of the esophagus, stomach, small and large bowel (colon), and liver. The Gastroenterologist and Hepatologist Dr. Zavos also maintains a forum in peptiko.gr with frequently asked questions and answers on various topics in Gastroenterology and Hepatology that are of a broader interest, and not case-specific. It is recommended that you contact with gastroenterologist Dr. Zavos by phone to ask for more information on your specific digestive tract problem, since the optimal management (diagnosis and treatment) of the patients requires obtaining a thorough and detailed history by the specialist and certainly clinical examination of the patient.

Gastroenterology focuses on the diagnosis and treatment of diseases of the digestive tract esophagus, stomach, small intestine and colon, pancreas and liver

The Scottish Medicines Consortium (SMC) has accepted AbbVie's RINVOQ (upadacitinib) for use within NHS Scotland for the treatment of adult patients with moderately to severely active ulcerative colitis (UC). Upadacitinib offers an additional treatment choice in the therapeutic class of janus kinase inhibitors. "Daily life with ulcerative colitis is difficult due to the debilitating and unpredictable nature of its symptoms", said Dr Jonathan Macdonald, Consultant Gastroenterologist at NHS Greater Glasgow and Clyde. "Clinical trials have shown that upadacitinib as a once daily pill controls symptoms in eight weeks for many patients and provided sustained responses at one year. The SMC's decision is good news for people with ulcerative colitis in Scotland as it provides an additional treatment option to help them gain control of their condition." The SMC decision is based on data from the induction studies U-ACHIEVE and U-ACCOMPLISH, as well as the Phase 3 U-ACHIEVE maintenance study, which demonstrated the efficacy of upadacitinib versus placebo in its ability to achieve clinical remission. The SMC's decision follows the granting of Marketing Authorisation for upadacitinib in UC in July 2022.

Best Gastroenterology Hospital in India Apollo Hospitals offer expert care in Medical Surgical Gastroenterology and focuses on treatment of digestive tract, liver pancreatic diseases